PEER MEDIA TECHNOLOGIES INCORPORATED (OTC: ARTD) "Up 435.71% in morning trading"
Originally incorporated as ARTISTdirect, Inc. in 1999, the company changed its name to Peer Media Technologies in 2010 after it acquired Media Defender in 2005 and Media Sentry in 2009 and sold its legacy music website business ARTISTdirect.com in 2010. The company is the leading provider of intellectual property protection and business intelligence services to major motion picture studios, record labels, television networks, gaming companies and software publishers.
TREE TOP INDUSTRIES INCORPORATED (OTC: TTII) "Up 31.87% in morning trading"
Tree Top is a development stage company, moving to acquire companies that are in various stages of development. Tree Top uses several different paradigms, including stock exchange, joint venture, cash, and other partnership configurations. Tree Top is a publicly listed, independently audited company that offers structure, transparency, and growth potential through various business paradigms. Tree Top can provide the means, through incubation, for domestic, foreign and international private companies to become part of a public entity in good standing, whose securities are publicly traded.
UNIVERSAL DETECTION TECHNOLOGY (OTCBB: UNDT) "Up 43.75% in morning trading"
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products.
CRYPTOLOGIC LIMITED (NASDAQ: CRYP) "Up 21.83% in morning trading"
Focused on integrity and innovation, CryptoLogic Limited is a leading developer and supplier of Internet gaming software. With more than 300 games, CryptoLogic has one of the most comprehensive casino suites on the Internet, with award-winning games featuring some of the world's most famous action and entertainment characters. The Company's licensees include many top Internet gaming brands. CryptoLogic's leadership in regulatory compliance makes it one of the few companies with gaming software certified to strict standards similar to land-based gaming. The CryptoLogic Group licenses gaming software and services to blue-chip customers that offer their games to non-U.S. based players around the world.
PRANA BIOTECHNOLOGY LIMITED (NASDAQ: PRAN) "Up 46.30% in morning trading"
Prana Biotechnology was established to commercialise research into Alzheimer's Disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the Australian Stock Exchange in March 2000 and listed on NASDAQ in September 2002. Researchers at prominent international institutions including The University of Melbourne, The Mental Health Research Institute (Melbourne) and Massachusetts General Hospital, a teaching hospital of Harvard Medical School, contributed to the discovery of Prana's technology.
MARSHALL EDWARDS INCORPORATED (NASDAQ: MSHL) "Up 34.97% in morning trading"
Marshall Edwards, Inc. is a specialist oncology company focused on the clinical development of novel anti-cancer therapeutics. These derive from a flavonoid technology platform, which has generated a number of novel compounds characterized by broad ranging activity against a range of cancer cell types with few side effects. The combination of anti-tumor cell activity and low toxicity is believed to be a result of the ability of these compounds to target an enzyme present in the cell membrane of cancer cells, thereby inhibiting the production of pro-survival proteins within the cell. Marshall Edwards has licensed rights from Novogen Limited (Nasdaq: NVGN) (ASX: NRT) to bring three oncology drugs — phenoxodiol, triphendiol and NV-143 — to market globally. Marshall Edwards' lead investigational drug, phenoxodiol, is in a Phase III multinational multi-centered clinical trial for patients with recurrent ovarian cancer.
About OTCPicks.com
OTCPicks.com, one of the leading penny stock Web sites, presents its daily Stocks to Watch and Midday Market Movers every weekday. In addition to all the latest penny stock news, OTCPicks also offers daily newsletters, unique commentaries and free profiles, alerts and investing tips.
The stocks presented above are available in OTCPicks.com's Free Daily Email Newsletter. For daily penny stock alerts CLICK HERE.
Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.
